Advertisement
UK markets close in 3 hours 19 minutes

  • FTSE 100

    8,097.03
    +56.65 (+0.70%)
     

  • FTSE 250

    19,727.93
    +8.56 (+0.04%)
     

  • AIM

    755.42
    +0.73 (+0.10%)
     

  • GBP/EUR

    1.1671
    +0.0027 (+0.23%)
     

  • GBP/USD

    1.2511
    +0.0049 (+0.39%)
     

  • Bitcoin GBP

    51,140.35
    -2,190.43 (-4.11%)
     

  • CMC Crypto 200

    1,358.50
    -24.08 (-1.74%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    83.00
    +0.19 (+0.23%)
     

  • GOLD FUTURES

    2,340.70
    +2.30 (+0.10%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,998.53
    -90.17 (-0.50%)
     

  • CAC 40

    8,030.45
    -61.41 (-0.76%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Mylan NV – Value Analysis (NASDAQ:MYL) : May 25, 2017

CapitalCube
Updated
Mylan NV – Value Analysis (NASDAQ:MYL) : May 25, 2017

Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Mylan NV a score of 72. Our analysis is based on comparing Mylan NV with the following peers – Impax Laboratories, Inc., Valeant Pharmaceuticals International Inc, Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Sanofi Sponsored ADR and Lannett Company, Inc. ... Read more (Read more...)

Continue reading